PMC:7696151 / 16555-16804
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 471 | 143-146 | Chemical | denotes | HCQ | MESH:D006886 |
| 472 | 216-219 | Chemical | denotes | HCQ | MESH:D006886 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T124 | 0-249 | Sentence | denotes | In light of these results, there was the need to consider that the first two described clinical trials, which reported the antiviral effect of HCQ, were on short-term treatments (8 or 16 weeks) and that they used an HCQ dosage of 800 mg/day [17,18]. |